aprepitant   Click here for help

GtoPdb Ligand ID: 3490

Synonyms: Aponvie® | Emend®
Approved drug PDB Ligand
aprepitant is an approved drug (FDA and EMA (2003))
Compound class: Synthetic organic
Comment: Aprepitant is a NK1 receptor antagonist.
Click here for help
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: aprepitant

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 8
Topological polar surface area 83.24
Molecular weight 534.15
XLogP 5.31
No. Lipinski's rules broken 1
Click here for help
Canonical SMILES Fc1ccc(cc1)C1C(OCCN1Cc1[nH][nH]c(=O)n1)OC(c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C
Isomeric SMILES Fc1ccc(cc1)[C@H]1[C@H](OCCN1Cc1[nH][nH]c(=O)n1)O[C@@H](c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C
InChI InChI=1S/C23H21F7N4O3/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)37-20-19(13-2-4-17(24)5-3-13)34(6-7-36-20)11-18-31-21(35)33-32-18/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H2,31,32,33,35)/t12-,19+,20-/m1/s1
No information available.
Summary of Clinical Use Click here for help
Antiemetic agent used in the treatment of nausea and vomiting associated with cancer chemotherapy. Use of aprepitant in pediatric patients was approved by the US FDA in September 2015. Aprepitant (Aponvie®) was FDA approved to treat postoperative nausea and vomiting in September 2022.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Aprepitant is a substance P analogue and acts as an antagonist of the neurokinin 1 receptor (NKR1). This prevents activation of NKR1 in the area of the medulla known as the vomiting center [3], and thereby reduces nausea and vomiting.
External links Click here for help